ft 18 may 92 intern compani news astra ulcer therapi threaten glaxo sale astra swedish pharmaceut group believ develop new therapi peptic ulcer could serious undermin sale zantac world best sell drug gener annual revenu dollar 3bn glaxo uk new treatment erad bacterium helicobact pylori hp specialist believ signific caus recur peptic ulcer elimin hp astra believ could reduc need long term prevent therapi glaxo estim 40 50 per cent zantac prescript long term mainten therapi astra test combin losec ulcer drug antibiot patient infect hp two studi reveal last week annual convent american gastroenterolog associ show drug could erad hp mani 80 per cent duoden ulcer patient patient remain ulcer free 12 month treatment effect erad hp new said mr robin gilbert pharmaceut analyst jame capel howev previou treatment elimin bug requir take 18 pill day five separ occas normal within hospit environ import new treatment one pill day prescrib gener practition would need combin fulfil earli promis could revolutionis market said mr gilbert mainten market could virtual disappear astra claim combin work losec reduc acid content stomach allow antibiot work effect antibiot abl withstand acid prove effect patient built resist